Page 12 - Cort Maa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cort maa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cort Maa Today - Breaking & Trending Today

Linden Thomas Advisory Services LLC Invests $1.24 Million in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Linden Thomas Advisory Services LLC bought a new position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 55,748 shares of the biotechnology company’s stock, valued at approximately $1,240,000. Other institutional investors also recently bought and sold shares of the company. CWM LLC increased […] ....

United States , Piper Sandler , Joseph Douglas Lyon , Danieln Swisher Jr , Linden Thomas Advisory Services , Canaccord Genuity Group , Tower Research Capital , Advisory Services Network , Securities Exchange Commission , Corcept Therapeutics Incorporated , Asset Management One Co , Free Report , Corcept Therapeutics , Management One , Services Network , Research Capital , Director Daniel , Douglas Lyon , Exchange Commission , Therapeutics Incorporated , Get Free Report , Genuity Group , Visit Holdingschannel , Corcept Therapeutics Daily , Nasdaq Cort , Sec Filings ,

Ingalls & Snyder LLC Sells 9,532 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)

Ingalls & Snyder LLC cut its position in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 0.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,360,485 shares of the biotechnology company’s stock after selling 9,532 shares during the quarter. Corcept Therapeutics makes up […] ....

United States , Sean Maduck , Piper Sandler , Atria Wealth Solutions Inc , Exchange Commission , Securities Exchange Commission , Boston Trust Walden Corp , Canaccord Genuity Group , Ingalls Snyder , Corcept Therapeutics Incorporated , Evanson Asset Management , Board Of Administration Florida Retirement System , Free Report , Corcept Therapeutics , Trust Walden Corp , State Employees Retirement System , Asset Management , Florida Retirement System , Atria Wealth Solutions , Hazel Hunt , Get Free Report , Genuity Group , Therapeutics Incorporated , Corcept Therapeutics Daily , Nasdaq Cort , Sec Filings ,

Corcept Therapeutics Incorporated (NASDAQ:CORT) Given Consensus Recommendation of "Hold" by Brokerages

Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) has received a consensus rating of “Hold” from the seven analysts that are covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among analysts that […] ....

United Kingdom , United States , Sean Maduck , Securities Exchange Commission , Asset Management One Co , Corcept Therapeutics Company Profile , Cambridge Investment Research Advisors Inc , Ingalls Snyder , Connor Clark Lunn Investment Management Ltd , Guggenheim Capital , Canaccord Genuity Group , Corcept Therapeutics Incorporated , Get Free Report , Corcept Therapeutics , Exchange Commission , Hazel Hunt , Investment Research Advisors , Lunn Investment Management , Management One , Therapeutics Stock Down , Get Free , Therapeutics Incorporated , Corcept Therapeutics Daily , Nasdaq Cort ,

Brokerages Set Corcept Therapeutics Incorporated (NASDAQ:CORT) Price Target at $30.81

Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) has been assigned a consensus rating of “Hold” from the seven brokerages that are covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average twelve-month price objective among analysts […] ....

United States , Sean Maduck , Piper Sandler , Danieln Swisher Jr , Canaccord Genuity Group , Lazard Asset Management , Corcept Therapeutics Incorporated , Tower Research Capital , Get Free Report , Genuity Group , Corcept Therapeutics , Director Daniel , Asset Management , Forest Capital Management , Research Capital , Therapeutics Stock Down , Get Free , Therapeutics Incorporated , Corcept Therapeutics Daily , Nasdaq Cort ,

Corcept Therapeutics' (CORT) Hold Rating Reaffirmed at Truist Financial

Corcept Therapeutics (NASDAQ:CORT – Get Free Report)‘s stock had its “hold” rating restated by Truist Financial in a report issued on Monday, Benzinga reports. They currently have a $29.00 price target on the biotechnology company’s stock. Truist Financial’s price target would suggest a potential upside of 9.93% from the stock’s current price. A number of […] ....

United States , Joseph Douglas Lyon , Sean Maduck , Piper Sandler , Canaccord Genuity Group , Tower Research Capital , Lazard Asset Management , Corcept Therapeutics Incorporated , Corcept Therapeutics , Get Free Report , Truist Financial , Genuity Group , Therapeutics Trading Down , Douglas Lyon , Asset Management , Forest Capital Management , Research Capital , Therapeutics Incorporated , Corcept Therapeutics Daily , Nasdaq Cort , Reiterated Rating , Truist Financial Co ,